Market Research Logo

Real World Evidence Solutions Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2024

Real World Evidence Solutions Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2024

The report on the global real world evidence solutions market provides qualitative and quantitative analysis for the period from 2016 to 2024. The report predicts the global real world evidence solutions market to grow with a CAGR of 14.6% over the forecast period from 2018-2024. The study on real world evidence solutions market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2016 to 2024.
The report on real world evidence solutions market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global real world evidence solutions market over the period of 2016 to 2024. Moreover, the report is a collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global real world evidence solutions market over the period of 2016 to 2024. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
• Real World Evidence Solutions Identify and Explore The Root Cause of Disease and Deliver More Insightful Information About the Patients
• Increasing Adoption of RWE in Pharmaceutical Companies
2) Restraints
• Lack Of Standardization and Limited Access to Real-world Data is Hindering the Market Growth
• Collaborations With Stakeholders Holding The Patient Data is one Of The Major challenge.
3) Opportunities
• Growing Awareness About the Real world Evidence Solutions Providers is Anticipated to Benefit the Real World Evidence Solutions Market

Research Methodology
A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from the industry
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global real world evidence solutions market is segmented on the basis of component, therapeutic area, and end-user.

The Global Real World Evidence Solutions Market by Component
• Pharmacy Data
• Claims Data
• Clinical Settings Data
• Patient-Powered Data
• Services

The Global Real World Evidence Solutions Market by Therapeutic Area
• Oncology
• Neurology
• Cardiovascular Disease
• Immunology
• Others

The Global Real World Evidence Solutions Market by End-user
• Healthcare Providers
• Healthcare Payers
• Pharmaceutical & Medical Device Companies
• Others

Company Profiles
The companies covered in the report include
• Syneos Health
• SAS Institute Inc.
• IQVIA
• Clinigen Group plc
• Cognizant
• ICON plc
• Oracle
• Pharmaceutical Product Development, LLC.
• IBM
• PAREXEL International Corporation

What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the real world evidence solutions market.
2. Complete coverage of all the segments in the real world evidence solutions market to analyze the trends, developments in the global market and forecast of market size up to 2024.
3. Comprehensive analysis of the companies operating in the global real world evidence solutions market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.


1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Real World Evidence Solutions Market Highlights
2.2. Real World Evidence Solutions Market Projection
2.3. Real World Evidence Solutions Market Regional Highlights
3. Global Real World Evidence Solutions Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Component
3.4.2. IGR-Growth Matrix Analysis by Therapeutic Area
3.4.3. IGR-Growth Matrix Analysis by End-user
3.4.4. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Real World Evidence Solutions Market
4. Real World Evidence Solutions Market Macro Indicator Analysis
5. Global Real World Evidence Solutions Market by Component
5.1. Pharmacy Data
5.2. Claims Data
5.3. Clinical Settings Data
5.4. Patient-Powered Data
5.5. Services
6. Global Real World Evidence Solutions Market by Therapeutic Area
6.1. Oncology
6.2. Neurology
6.3. Cardiovascular Disease
6.4. Immunology
6.5. Others
7. Global Real World Evidence Solutions Market by End-user
7.1. Healthcare Providers
7.2. Healthcare Payers
7.3. Pharmaceutical & Medical Device Companies
7.4. Others
8. Global Real World Evidence Solutions Market by Region 2018-2024
8.1. North America
8.1.1. North America Real World Evidence Solutions Market by Component
8.1.2. North America Real World Evidence Solutions Market by Therapeutic Area
8.1.3. North America Real World Evidence Solutions Market by End-user
8.1.4. North America Real World Evidence Solutions Market by Country
8.2. Europe
8.2.1. Europe Real World Evidence Solutions Market by Component
8.2.2. Europe Real World Evidence Solutions Market by Therapeutic Area
8.2.3. Europe Real World Evidence Solutions Market by End-user
8.2.4. Europe Real World Evidence Solutions Market by Country
8.3. Asia-Pacific
8.3.1. Asia-Pacific Real World Evidence Solutions Market by Component
8.3.2. Asia-Pacific Real World Evidence Solutions Market by Therapeutic Area
8.3.3. Asia-Pacific Real World Evidence Solutions Market by End-user
8.3.4. Asia-Pacific Real World Evidence Solutions Market by Country
8.4. RoW
8.4.1. RoW Real World Evidence Solutions Market by Component
8.4.2. RoW Real World Evidence Solutions Market by Therapeutic Area
8.4.3. RoW Real World Evidence Solutions Market by End-user
8.4.4. RoW Real World Evidence Solutions Market by Sub-region
9. Company Profiles and Competitive Landscape
9.1. Competitive Landscape in the Global Real World Evidence Solutions Market
9.2. Companies Profiles
9.2.1. Syneos Health
9.2.2. SAS Institute Inc.
9.2.3. IQVIA
9.2.4. Clinigen Group plc
9.2.5. Cognizant
9.2.6. ICON plc
9.2.7. Oracle
9.2.8. Pharmaceutical Product Development, LLC.
9.2.9. IBM
9.2.10. PAREXEL International Corporation
10. Appendix
10.1. Primary Research Findings and Questionnaire

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report